Food and Drug Administration

Sarepta Faces Scrutiny from Press, Investors, Lawyers —...

FOIAengine: Maker of Elevidys Targeted by 91 FOIA Requests in 19 Months As biotech firm...

ExodusPoint Gains A Unique Advantage

FOIAengine: Decoding How a Hedge Fund Tracks FDA Requests ExodusPoint burst onto the hedge fund...

Questions About High-Flying Insulet Corp.

FOIAengine: Multiple Hedge Funds Seeking Inspection Reports Leading medical device manufacturer Insulet Corporation’s stock price...

New Questions about FDA and Pharma

FOIAengine: Revolving Door Hits Pfizer on the Way Out The revolving door between the Food...

Media Seeks Kennedy’s Recent FDA Contacts

FOIAengine: HHS Designee Is Target After Calling FDA “Corrupt” Freedom of Information Act requests from...

The Agony Around Ecstasy

FOIAengine: Media Requests Signaled Issues for a “Party Drug” Going Mainstream With 153 clinical trials...

The Glomar Hustle

FOIAengine Explores the Widespread Use of “Neither Confirm Nor Deny” By John A. Jenkins We’re taking...

Public Right, Private Privilege: Commercial Entities are Biggest...

FOIAengine Reveals Trends Behind the Big Numbers at FDA, SEC   This week we analyze...